Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate

NCT: NCT05155891 · ACTIVE_NOT_RECRUITING

NCT IDNCT05155891
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-17
Completion2027-12-01

Brief Summary

The purpose of this research study is to evaluate prostate artery embolization (PAE) compared to Holmium laser enucleation of prostate (HoLEP) in improving a patient's overall prostate related symptoms.

Frequently Asked Questions

What is Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate?

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate is a clinical trial registered under NCT05155891. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05155891?

The current status of NCT05155891 (Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate) is: ACTIVE_NOT_RECRUITING.

When did Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate start?

Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate started on 2022-06-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑